Author: Ken Dropiewski

Leviticus Cardio & Jarvik Heart Unveil Groundbreaking Wireless Heart Pump System

PETAH TIKVA, Israel, Feb. 6, 2019 /PRNewswire/ — A groundbreaking piece of medical technology was revealed to the public today at the National Research Center for Cardiac Surgery in Astana, Kazakhstan. At a press conference held at the Center, top heart failure experts from around the world announced the successful implantation of FIVAD (Fully Implanted Ventricular Assist […]

According to THE SAGE GROUP, Thrombus is Highly Prevalent in Both Symptomatic and Asymptomatic Peripheral Artery Disease (PAD) Patients

BEAUFORT, S.C.–(BUSINESS WIRE)–A new analysis published by THE SAGE GROUP concludes that occlusive thrombus is present in 3.6 million PAD patients. “Occlusive thrombus in the leg arteries has serious consequences including ischemic symptoms, and in severe cases amputation. Furthermore, its presence adversely affects interventional procedure outcomes and costs. Thrombus interferes […]

REVA Announces Reduction in Force

SAN DIEGO, Feb. 04, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced it is realigning the organization to align with current business conditions. Effective February 8, 2019, REVA will reduce its San Diego-based personnel to […]

BioSig Appoints John Kowalski to Lead Commercialization of PURE EP

Santa Monica, CA, Feb. 05, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company has appointed Mr. John Kowalski as Vice President of Sales. Mr. […]

Kaneka invests in a US-based medical device company

TOKYO, Feb. 4, 2019 /PRNewswire/ — Kaneka Corporation (Tokyo, Japan, President: Mamoru Kadokura) has entered into an investment and strategic agreement with an undisclosed US-based medical device company (“Company”). According to this agreement, Kaneka has made an investment in 18.5% shares of the Company and plans to start sales as the exclusive distributor […]

American College of Cardiology Acquires MedAxiom

WASHINGTON, Feb. 4, 2019 /PRNewswire/ — The American College of Cardiology Foundation has acquired MedAxiom, a cardiovascular membership, services and consulting firm, adding the company’s recognized leadership in cardiovascular operations, performance improvement, and business acumen to ACC’s world class science, education, registry, quality improvement and advocacy work. Through this acquisition, the ACC will expand […]

Teleflex Announces U.S. FDA Premarket Approval of MANTA™ Vascular Closure Device

WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that it received premarket approval (PMA) from the U.S. Food and Drug Administration for the MANTA™ Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically […]

BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

FRANKLIN LAKES, N.J., Feb. 5, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.160 billion for the first fiscal quarter ended December 31, 2018.  This represents an increase of 35.1 percent from the prior-year period, which is primarily due to the acquisition of […]

AtriCure to Announce Fourth Quarter and Full Year 2018 Financial Results

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its fourth quarter and full year 2018 financial results on Thursday, February 28, 2019. AtriCure will host a conference call at 4:30 p.m. Eastern […]